119 related articles for article (PubMed ID: 32248301)
1. Primary anatomical site as a prognostic factor for pleomorphic liposarcoma.
Lee HG; Aurit S; Silberstein P; Gootee J
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1501-1508. PubMed ID: 32248301
[TBL] [Abstract][Full Text] [Related]
2. Primary anatomical site, adjuvant therapy, and other prognostic variables for dedifferentiated liposarcoma.
Gootee J; Aurit S; Curtin C; Silberstein P
J Cancer Res Clin Oncol; 2019 Jan; 145(1):181-192. PubMed ID: 30361927
[TBL] [Abstract][Full Text] [Related]
3. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.
Pearlstone DB; Pisters PW; Bold RJ; Feig BW; Hunt KK; Yasko AW; Patel S; Pollack A; Benjamin RS; Pollock RE
Cancer; 1999 Jan; 85(1):85-92. PubMed ID: 9921978
[TBL] [Abstract][Full Text] [Related]
4. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
Dalal KM; Kattan MW; Antonescu CR; Brennan MF; Singer S
Ann Surg; 2006 Sep; 244(3):381-91. PubMed ID: 16926564
[TBL] [Abstract][Full Text] [Related]
5. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
Massi D; Beltrami G; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
[TBL] [Abstract][Full Text] [Related]
6. Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases.
Azumi N; Curtis J; Kempson RL; Hendrickson MR
Am J Surg Pathol; 1987 Mar; 11(3):161-83. PubMed ID: 3826477
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases.
Hornick JL; Bosenberg MW; Mentzel T; McMenamin ME; Oliveira AM; Fletcher CD
Am J Surg Pathol; 2004 Oct; 28(10):1257-67. PubMed ID: 15371941
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of histologic subtypes in primary extremity liposarcoma.
Chang HR; Hajdu SI; Collin C; Brennan MF
Cancer; 1989 Oct; 64(7):1514-20. PubMed ID: 2776110
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases.
Downes KA; Goldblum JR; Montgomery EA; Fisher C
Mod Pathol; 2001 Mar; 14(3):179-84. PubMed ID: 11266523
[TBL] [Abstract][Full Text] [Related]
10. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group.
Gebhard S; Coindre JM; Michels JJ; Terrier P; Bertrand G; Trassard M; Taylor S; Château MC; Marquès B; Picot V; Guillou L
Am J Surg Pathol; 2002 May; 26(5):601-16. PubMed ID: 11979090
[TBL] [Abstract][Full Text] [Related]
11. Pleomorphic liposarcoma.
Oliveira AM; Nascimento AG
Semin Diagn Pathol; 2001 Nov; 18(4):274-85. PubMed ID: 11757868
[TBL] [Abstract][Full Text] [Related]
12. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of liposarcomas-a study of 106 cases.
Khan N; Ud Din H; Hashmi SN; Muhammad I; Atique M; Khadim T; Akhtar F
J Ayub Med Coll Abbottabad; 2014; 26(3):320-2. PubMed ID: 25671937
[TBL] [Abstract][Full Text] [Related]
14. Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution.
Muratori F; Frenos F; Bettini L; Matera D; Mondanelli N; Scorianz M; Cuomo P; Scoccianti G; Beltrami G; Greto D; Livi L; Baldi G; Roselli G; Capanna R; Campanacci DA
J Orthop Sci; 2018 Nov; 23(6):1038-1044. PubMed ID: 30007495
[TBL] [Abstract][Full Text] [Related]
15. Pleomorphic liposarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic study of 32 additional cases.
Wang L; Ren W; Zhou X; Sheng W; Wang J
Pathol Int; 2013 Nov; 63(11):523-31. PubMed ID: 24274714
[TBL] [Abstract][Full Text] [Related]
16. Giant ulcerated pleomorphic liposarcoma of the chest wall.
Fernández EL; Plasencia LD; Palma JP; Pallares AC
J Thorac Oncol; 2007 Dec; 2(12):1126-7. PubMed ID: 18090587
[TBL] [Abstract][Full Text] [Related]
17. Liposarcoma of the head and neck: analysis of 318 cases with comparison to non-head and neck sites.
Gerry D; Fox NF; Spruill LS; Lentsch EJ
Head Neck; 2014 Mar; 36(3):393-400. PubMed ID: 23728920
[TBL] [Abstract][Full Text] [Related]
18. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
[TBL] [Abstract][Full Text] [Related]
19. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of "dedifferentiation".
Weiss SW; Rao VK
Am J Surg Pathol; 1992 Nov; 16(11):1051-8. PubMed ID: 1471725
[TBL] [Abstract][Full Text] [Related]
20. Important prognostic factors in leiomyosarcoma survival: a National Cancer Database (NCDB) analysis.
Gootee J; Sioda N; Aurit S; Curtin C; Silberstein P
Clin Transl Oncol; 2020 Jun; 22(6):860-869. PubMed ID: 31392646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
